Matches in Wikidata for { <http://www.wikidata.org/entity/Q91011625> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q91011625 description "article scientifique publié en 2019" @default.
- Q91011625 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91011625 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91011625 description "scientific article published on 31 October 2019" @default.
- Q91011625 description "wetenschappelijk artikel" @default.
- Q91011625 description "наукова стаття, опублікована 31 жовтня 2019" @default.
- Q91011625 name "Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy" @default.
- Q91011625 name "Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy" @default.
- Q91011625 type Item @default.
- Q91011625 label "Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy" @default.
- Q91011625 label "Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy" @default.
- Q91011625 prefLabel "Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy" @default.
- Q91011625 prefLabel "Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy" @default.
- Q91011625 P1433 Q91011625-3A1B80A4-0EDA-4CDE-996D-432EAF237EF8 @default.
- Q91011625 P1476 Q91011625-A5DE7B3C-4D12-4725-A8D6-03A665971F09 @default.
- Q91011625 P2093 Q91011625-4670738A-9B12-4E3E-9B7E-23B57C142B5A @default.
- Q91011625 P2093 Q91011625-7F719E9A-61C0-4094-A833-B7A1047B7FD8 @default.
- Q91011625 P2093 Q91011625-E1104395-A617-4318-BA8B-554512F0EE65 @default.
- Q91011625 P2093 Q91011625-EB490FE3-30BD-40BB-B5E3-F337E807C41B @default.
- Q91011625 P2093 Q91011625-F5F7F35F-5816-49B5-A0CF-0FE4C4C6DB50 @default.
- Q91011625 P304 Q91011625-F8F86C70-C0B0-4DF8-BD9A-E37C7BA6421C @default.
- Q91011625 P31 Q91011625-71EA90C9-D5F5-4357-A2FE-0D41100BAC8B @default.
- Q91011625 P356 Q91011625-4433907F-E787-4ECF-BA97-16818FFFA4AF @default.
- Q91011625 P433 Q91011625-8BC60E4C-F782-4384-9912-C945726724D4 @default.
- Q91011625 P478 Q91011625-F9A557C6-8DD0-4D97-80BB-6FFB6FFC8E75 @default.
- Q91011625 P577 Q91011625-CB8967BB-FA33-4D71-B94A-4B1847D9091F @default.
- Q91011625 P698 Q91011625-DB286C58-37E8-4A4D-8269-DC00F9AD5D03 @default.
- Q91011625 P921 Q91011625-FD14A51F-549A-45ED-A7FB-CA715A8412A4 @default.
- Q91011625 P932 Q91011625-01534A0C-3B54-414F-97E7-5C1299D0B67C @default.
- Q91011625 P356 INTERNALMEDICINE.3902-19 @default.
- Q91011625 P698 31666471 @default.
- Q91011625 P1433 Q6047666 @default.
- Q91011625 P1476 "Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy" @default.
- Q91011625 P2093 "Hiroshi Sawachika" @default.
- Q91011625 P2093 "Shintaro Yamamoto" @default.
- Q91011625 P2093 "Shunichi Fujita" @default.
- Q91011625 P2093 "Tomoyuki Mukai" @default.
- Q91011625 P2093 "Yoshitaka Morita" @default.
- Q91011625 P304 "597-598" @default.
- Q91011625 P31 Q13442814 @default.
- Q91011625 P356 "10.2169/INTERNALMEDICINE.3902-19" @default.
- Q91011625 P433 "4" @default.
- Q91011625 P478 "59" @default.
- Q91011625 P577 "2019-10-31T00:00:00Z" @default.
- Q91011625 P698 "31666471" @default.
- Q91011625 P921 Q13896859 @default.
- Q91011625 P932 "7056381" @default.